| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0079 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |